|
TTBK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.741900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.720800E-03 |
| Normal-vs-Stage2 |
3.734400E-01 |
| Normal-vs-Stage3 |
1.168170E-01 |
| Normal-vs-Stage4 |
3.406400E-01 |
| Stage1-vs-Stage2 |
5.013000E-01 |
| Stage1-vs-Stage3 |
9.927800E-01 |
| Stage1-vs-Stage4 |
9.948400E-01 |
| Stage2-vs-Stage3 |
6.241000E-01 |
| Stage2-vs-Stage4 |
7.038600E-01 |
| Stage3-vs-Stage4 |
9.997000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.020200E-03 |
| Normal-vs-AfricanAmerican |
1.151930E-02 |
| Normal-vs-Asian |
4.30599999989845E-07 |
| Caucasian-vs-AfricanAmerican |
6.667000E-01 |
| Caucasian-vs-Asian |
1.789150E-04 |
| AfricanAmerican-vs-Asian |
2.121800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.190000E-04 |
| Normal-vs-Female |
9.955200E-01 |
| Male-vs-Female |
3.300900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.842300E-02 |
| Normal-vs-Extreme_Weight |
1.583350E-04 |
| Normal-vs-Obese |
2.281000E-01 |
| Normal-vs-Extreme_Obese |
1.034320E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.992600E-01 |
| Normal_Weight-vs-Obese |
3.262200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.159600E-01 |
| Extreme_Weight-vs-Obese |
3.465700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.133600E-01 |
| Obese-vs-Extreme_Obese |
1.632170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.057000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.641200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.377370E-04 |
| Normal-vs-Age(81-100Yrs) |
7.7839000000024E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.658000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.031200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.206100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.729890E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.444100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.828030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.662740E-03 |
| Normal-VS-Type2 PRCC |
1.716410E-03 |
| Normal-VS-KIRP CIMP |
7.885800E-01 |
| Normal-VS-Unclassified PRCC |
6.536600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.348400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.054770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.536100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.112000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.380300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.913800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83750000000349E-05 |
| Normal-vs-N1 |
1.224180E-01 |
| Normal-vs-N2 |
8.008400E-01 |
| N0-vs-N1 |
2.840800E-01 |
| N0-vs-N2 |
6.675800E-01 |
| N1-vs-N2 |
8.174400E-01 |
|
|
